OpenVSafe by OpenVAERS
Search V-safe

732-58469-17925

3 vaccinations 7 coded responses 23 check-ins 7 free-text entries 4 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
986 / WA
Registered
2021-01-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-26
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-27
    Registered in v-safe
  3. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rhinorrhoea, Sinus congestion — Feeling: Good
    Free text: Runny nose, sinus congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-31
    Survey response — days 1–6 daily, dose 1
    MedDRA: Paranasal sinus hypersecretion — Feeling: Good
    Free text: Sinus drip
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hypotension — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Very low blood pressure eventually returning to normal
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-01
    Report sent to call center — days 1–6 daily, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-02-02
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-11
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-16
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-16
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-23
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache
    Adult check-in
  14. 2021-03-02
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-09
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-16
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-30
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-06-15
  21. 2021-08-17
    Survey response — 6 months, dose 2
    MedDRA: Pulmonary embolism, Supraventricular tachycardia, Thrombosis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Supraventricular tachycardia Pulmonary embolism Blood clots in legs
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  22. 2021-08-17
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  23. 2021-08-19
  24. 2021-09-06
    Dose 3 — Pfizer-BioNTech
  25. 2021-09-29
    Survey response — day 21, dose 3
    MedDRA: Pulmonary embolism, Pulmonary thrombosis, Supraventricular tachycardia, Thrombosis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Supraventricular tachycardia, leg and lung clots/ pulmonary embolism
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-09-29
    Report sent to call center — day 21, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  27. 2021-09-30
  28. 2021-10-04
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-10-05
  30. 2021-10-11
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-10-18
    Survey response — day 42, dose 3
    MedDRA: Cough, Headache, Sinus congestion — Feeling: Good
    Free text: Sinus congestion, cough, headache
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-12-06
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-03-07
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-09-06
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Lung disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: COVID 19 despite 2 vaccinations and 2 boosters. Symptoms lasted 4 days with pulmonary weakness for another 2 week. Date of first symptoms July 4. Had used masks consistently.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-09-06
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  36. 2022-09-07
  37. 2022-09-07
  38. 2022-09-07
  39. 2022-09-07

Vaccinations

DoseDateManufacturerCo-administered
12021-01-26Pfizer-BioNTech
22021-02-16Pfizer-BioNTech
32021-09-06Pfizer-BioNTech No

Call center

4 call center cases

4 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 1

2021-01-28

Systemic reaction (other): Runny nose, sinus congestion

2021-01-31

Systemic reaction (other): Sinus drip

2021-02-01

Systemic reaction (other): Very low blood pressure eventually returning to normal

Release 9 — 6 months, dose 2

2021-08-17

Symptoms: Supraventricular tachycardia Pulmonary embolism Blood clots in legs

Release 9 — day 21, dose 3

2021-09-29

Symptoms: Supraventricular tachycardia, leg and lung clots/ pulmonary embolism

Release 10 — day 42, dose 3

2021-10-18

Symptoms: Sinus congestion, cough, headache

Release 12 — 12 months, dose 3

2022-09-06

Symptoms: COVID 19 despite 2 vaccinations and 2 boosters. Symptoms lasted 4 days with pulmonary weakness for another 2 week. Date of first symptoms July 4. Had used masks consistently.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDCOVID-19 · · ✓
SDHeadache · · ✓
SDLung disorder · · ✓
SDPulmonary embolism ✓ · ✓
SDPulmonary thrombosis · · ✓
SDSinus congestion · · ✓
SDSupraventricular tachycardia ✓ · ✓
SDThrombosis ✓ · ✓
SROHypotension ✓ ✓ ✓
SROParanasal sinus hypersecretion ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓
SROSinus congestion ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release